The LRP16 gene (GenBank accession number: AF202922) is a novel human gene that was cloned using rapid amplification of cDNA end (RACE) technology from healthy human peripheral blood mononuclear cells in December 1999 by Yu ., 1, 2 through comparing the status of differential DNA methylation of newly diagnosed and relapsed acute myeloid leukemia cells by methylationsensitive restriction landmark genomic scanning (RLGS). Our previous studies have shown that was closely correlated with pathogenesis and lymph node metastasis of breast cancer, and therefore was possibly an oncogene.
3 To further explore the biologic functions of LRP16 , we used bioinformatics methods to predict the structure and function of the LRP16 gene promoter and its encoded protein, as well as verified its roles in promoting tumor proliferation, regulating the cell cycle, and repairing DNA damage.
The pGL3 Luciferase Reporter Vectors, the pGEMT Easy Vector, and E. coli strain JM109 were products of Promega Inc. pcDNA3.1 (+) eukaryotic expression vector was provided by the Immunology Department at the Liberation Army General Hospital Basic Science Institute.
Peripheral blood mononuclear cells were derived from a healthy male blood donor at the Liberation Army General Hospital and extracted by density gradient centrifugation. The human breast cancer cell line MCF7 and the myeloid leukemia cell line K562 were generous gifts from Prof. YiMing Mu from the Department of Endocrinology at the Liberation Army General Hospital. The acute promyelocytic cell line HL60 was stock at the Hematology Laboratory of the Liberation Army General Hospital. MCF7, K562, and HL60 cells were cultured using Dulbecco's modified eagle medium (DMEM) and RPMI1640 containing 10% fetal bovine serum, with 100 u/mL of penicillin and 100 滋 g/mL of streptomycin, respectively, at 37益 in 5% CO 2 .
Data were all from openaccess free databases on the web. Promoter analysis software including Genomatix MatInspector Release professional 5.3, Regulatory Sequence Analysis Tools (RSAtools), and Transcription Element Search System (TESS) were used to carry out the threepattern analysis (that is, unknown cisacting element screening, database analysis of known cisacting elements, and frequency analysis of known cisacting elements).
For the structure and function prediction of the encoded protein, we used the LRP16 gene transcription product as the target sequence to search ORFs in the human genome database and applied a computeraided system to predict the primary, secondary, and tertiary structures of the LRP16 protein. Domain search was used to search for homologous proteins to the LRP16encoded protein or those with similar structures. Software and related databases included Open Reading Frame Finder (ORF Finder), Clusters of Orthologous Groups of Proteins (COGs), GarnierOsguthorpeRobson (GOR), and SwissProt.
Referring to the method design in the literature, 4 we synthesized a 3.0kilobase (kb) promoter at the 5' flanking region of LRP16 and polymerase chain reaction (PCR) primers for promoter subcloning, of a total of 10 fragments. The sequences were 5'GACATTGCCAGGAAGGTTGCA3' for P1, 5'TCCAGTCGGT GGAGGTGCTCA3' for P2, 5'GAGCTC ( Ⅰ )CGCGCTGGCT TTGAACATGG3' for Pu0 (2.6), 5'GAGCTC(
for Pu6 (0.2), and 5'AAGCTT ( d 芋 )CCGCCCACTTGGACT CTATTT3' for Pd.
Each subcloned promoter fragment differed by about 400 bp, with an identical 3' end and a different 5' end, that is, S0 (2.6 kb), S1 (2.2 kb), S2 (1.7 kb), S3 (1.4 kb), S4 (1.0 kb), S5 (0.6 kb) and S6 (0.2 kb) respectively. The construction of the LRP16 2.6kb promoterpGL3Basic vector recombinant: Trizol was used to extract genomic DNA and a nestedPCR method was applied for DNA amplification. The PCR products were purified, recovered from the gel, and subjected to restriction enzyme digestion verification. The purified PCR products were ligated to the pGEMT plasmid to construct the LRP16 promoterpGEMT vector recombinant, transformed into JM109
, and screened by the blue/white test plus a seminested PCR assay. The positive clones were sent for DNA sequencing. The 2.6kb promoter of LRP16 with the fully matched sequencing result to the genome sequence was ligated to the pGL3Basic plasmid to construct the LRP16 S0pGL3Basic vector recombinant. After blue/white screening and seminested PCR screening, the positive clones were sent for DNA sequencing again. Construction of the subcloned LRP16 gene promoterpGL3 Basic vector recombinants: the above subcloned promoterpGL3 Basic vector recombinants were constructed based on the existing LRP16 geneS0pGL3Basic vector.
MCF7 cells of about 40% confluence were selected and transiently transfected with the LRP16 gene promoter and the subcloned promoterpGL3Basic plasmid recombinants using SuperFect transfection by Qiagen, following the manual instructions. At 24 h after transfection, Promega Luciferase Assay Kit Chemiluminescence luminol was used to detect Renilla luciferase intensity, following the instructions.
The onestep Trizol method was used to extract total RNA from the peripheral blood mononuclear cells, according to the instructions.
The fulllength LRP16 gene ORF was amplified by reverse transcriptionpolymerase chain reaction (RTPCR) and ligated to the pGEMT plasmid to construct the fulllength LRP16 gene ORFpGEMT vector recombinant. The primers for the fulllength LRP16 gene ORF were designed and synthesized. The sequences were 5'GG (Protector)GGTACC ( I site) ATGGCGGCGAAGGTGG3' for upstream primer and 5'CG (Protector)GGATCC ( H 玉 site)GGCCACGGGGAAGTAGT G3' for downstream primer, with a PCR product size of 975 bp. The PCR reaction conditions were 94益 denaturation for 5 min, then 94益 1 min, 62益 annealing 50 s and 72益 1 min for 33 cycles, followed by 72益 final extension for 10 min, and the reaction was terminated at 4益 . The obtained PCR product was ligated to the pGEMT Easy Vector using T4 DNA ligase and transformed into JM109
. Blue/white screening was used to search for positive clones, and restriction enzyme digestion and sequencing were used for verification. The GPI gene was selected as an internal control. The primer sequences for GPI were GPI1: 5'GACCCCCAGTTCCAGAAGCTG3' and GPI2: 5'GCATCACGTCCTCCGTCACC3', yielding a PCR product of 196 bp.
Construction of the fulllength LRP16 gene ORFpcDNA3.1(+) plasmid: The fulllength LRP16 ORF with a confirmed sequence was named LLRP16. The obtained positive LLRP16pGEMT plasmid and the pcDNA3.1 (+) plasmid were subjected to double digestion by I and H I endonucleases. The digestion products were subjected to 1% agarose gel electrophoresis. The digested fragments were recovered from agarose gel. LLRP16 was inserted into the pcDNA3.1 (+) plasmid by T4 DNA ligase to construct the LLRP16pcDNA3.1(+) plasmid and transformed into JM109. The positive clones were verified by 玉 and H 玉 double digestion and sequencing to ensure the correct sequence and orientation of the inserted LLRP16. The LLRP16pcDNA3.1 (+) clone with the correct sequence was selected to transfect HL60 cells using the Superfect lipofection reagent by Qiagen according to the instructions. At 24 h after transfection, the culture medium containing 800 滋 g/mL G418 was supplied for 1 week to screentransfected cells and 200 滋 g/mL G418 was supplied as a maintenance concentration. LRP16 mRNA expression was detected by RTPCR. The HL60 cell line stably overexpressing LRP16 was obtained after 1 month. At the same time, the pcDNA3.1 (+) plasmid transfected HL60 cells were used as an empty plasmid control.
Detection of UV damage: Cell concentration was adjusted to 2伊 10 6 cells/mL and cultured in a 6well plate in suspension. After removing the cover, the cells were irradiated immediately by UV light (360 nm, 40 W ) for 10 min, with an irradiation distance of 40 cm. Samples were collected at 4 h and 24 h after the irradiation. Trypan blue staining was used to count living cells and singlecell gel electrophoresis (SCGE) was applied to detect nuclear DNA damage.
5 Triplicate wells were tested for each sample and 20 cells in continuous fields were observed for each well. The experiment was repeated 3 times and the final result was calculated by averaging the 3 experiments.
LLRP16pcDNA3.1 (+) was transfected into K562 cells to establish a K562 cell line that stably overexpressed LRP16, using the above method for the HL60 cell line. At the same time, pcDNA3.1 (+) plasmid was transfected into the K562 cells as an empty plasmid control. Trypan blue staining was used to count the living cells and a growth curve was plotted. A serumfree culture was used for cellcycle synchronization and then the serum was added in the culture medium. A solution of 75% ethanol was added to the cells at different culture stages. Cells were frozen at 20益 and stained by propidium iodide, and the cell cycle was tested using flow cytometry.
Statistical analysis was performed using SPSS12.0 software. Differences were detected by test and the level of significance was set as 琢 = 0.05.
A total of 7 subcloned LRP16 gene promoterluciferase reporter recombinants were obtained and named pGL3S0, pGL3S1, pGL3S2, pGL3S3, pGL3S4, pGL3S5, and pGL3S6, respectively. The correct ligation of the 7 subcloned LRP16 gene promoters with the pGL3Basic vector was verified by 玉 and d芋 doubleenzyme digestion and DNA sequencing.
The detection of luciferase activity showed that the subcloned LRP16 gene promoters could regulate the expression of luciferase, among which pGL3S5 had the strongest regulatory function, indicating that the core regulatory sequence of LRP16 located at the 1 bp to 600 bp region upstream of ORF might execute a major regulatory function on gene expression. In addition, the activities of pGL3S0, pGL3S1, pGL3S2, pGL3S3, and pGL3S4 were all relatively weaker than that of pGL3S5, suggesting the existence of a negatively regulatory cisstructure (Fig. 1) .
The DNA sequence at the 5' flanking region of LRP16 had characteristics of a typical type II eukaryotic promoter. The general constitutive promoter elements included a TATA box (75 bp to 56 bp upstream to ORF), a GC box (236 bp to 224 bp upstream), and a transcription initiation site (52 bp upstream), to name a few.
In the promoter region of LRP16, some cisacting elements had obvious regionspecific distribution. For example, some cisregulatory elements had multiple repeat sequences in the core regulatory region, a region equivalent to an approximately 400bp fragment located between the subcloned promoter S5 and S6 (623 bp to 200 bp), while no or little repeat sequences presented in the rest of the 3000 bp. This 400bp region contained regulatory sequences with the highest promoter activity. Since cisacting elements such as TAg, IL6, ZF5, Ets, estrogen receptor, retinoic acid receptor, and XPF1 had multiple repeat sequences in the core regulatory region too, we speculated that LRP16 might be a functional gene closely related to some physiologic and pathologic processes such as the cell cycle, hematopoietic regulation, cell differentiation, tumorigenesis, stress responses, and others.
We successfully amplified a 975bplong target fragment, and an identical sequence of the fulllength LRP16 ORF to the human genome was confirmed by sequencing. The fulllength LRP16 gene ORFpcDNA3.1 (+) eukaryotic expression vector was successfully constructed. That is, the LLRP16pcDNA3.1 (+) and transfected into the HL60 and K562 cell lines to obtain cells stably overexpressing LRP16 (Fig. 2) .
The transcription product of LRP16 was 1030 bp long and its ORFinitiation site was located at 53 bp downstream to the transcriptioninitiation site. ORF Finder predicted 3 potential ORFs with a different Nterminus and an identical Cterminus, which were respectively 325 aa, 283 aa, and 195 aa in length. The fulllength geneencoded protein had a molecular weight of 35 505.11 and theoretical pI value of 9.58, as well as was rich in glycine (8.3% ) and leucine (11.1% ). The secondary structure prediction showed that it was a protein with mixed secondary structures, α helix accounting for 36.0% , β folding accounting for 13.9% , and other structures accounting for 50.2% of the secondary structures. There were total of 6 known modification sites, including glycosylation sites, protein kinase C phosphorylation sites, casein kinase 域 phosphorylation sites, tyrosine kinase phosphorylation sites, N14 (alkyl) acylation sites, and amidation sites. The US National Center for Biotechnology Information (NCBI) human protein database comparison and analysis found that at 148315 amino acid residues, the LRP16encoded protein had homologous sequences to the end of the human histone H2A1C including hismacro, COG2110, and A1pp sequences (Fig. 3A) , which showed up to 80% homology. Based on that, it is possible that LRP16 might be closely related to chromosome structure stability and DNA damage repair. The LRP16encoded protein is likely to belong to an ancient protein family in biologic evolution, since the homologous sequences of LRP16 were identified across ancient bacteria to rodents (Fig.  3B) .
SCGE test results showed that the overexpression of LRP16 in HL60 cells had an antiDNA damage effect at 4 h after irradiation. Compared to the control group, the cometlike tail length in the overexpression group was shorter at 4 h and 24 h after irradiation (Fig. 4) and the number of cometlike cells were fewer (Table 1) , while the number of living cells was greater (Table 1) 
Compared with the empty vector control group, LRP16 overexpression had a proliferation/promoting effect on K562 cells (Fig. 5) . Cellcycle analysis revealed that at the same time point, the cell number and ratio in the M phase and the S phase were significantly more in K562 cells with LRP16 overexpression than in the control group. In addition, the 6th day growth plateau in the serumcontaining culture was reached at an earlier time in the overexpression group. Accordingly, cells in the S phase were fewer than the control group (Fig. 6 ).
LRP16 is a novel human gene cloned by researchers from China.
1 Since some of the LRP16 gene expression sequence tags (ESTs) were derived from recurrent acute myeloid leukemia while the fulllength gene was cloned from healthy human peripheral blood mononuclear cells, it suggests that LRP16 may be an important functional gene expressed in both healthy individuals and in patients with leukemia. Therefore, it is necessary to conduct indepth studies on its function.
Studies by Han . 6,7 found that LRP16 was subject to regulation by estrogen and androgen and its high expression was closely correlated with the growth, invasion, and metastasis of breast and prostate cancers. However, currently the biologic functions of LRP16 in the pathogenesis and development of leukemia are not clear.
8
In this study, we preliminarily predicted the function of human LRP16 using a combination of cisacting element analysis of the promoter region and traditional gene function prediction methods, that is, protein structure and function prediction, functional domain homology analysis, and phylogenetic tree analysis of sequence similarity. 9 In addition, we confirmed the predicted function of LRP16 in leukemia cell lines, and our results showed that LRP16 could promote K562 cell proliferation, regulate the cell cycle switch from the G 0 phase to the S phase, and reduce DNA damage induced by UV.
The analysis of the cisacting element in the promoter region improved the accuracy of traditional gene function analysis and could be used as a powerful complementary tool for genefunction prediction. Through establishing a 2.6kb LRP16gene promoter and subcloned promoters differing by 400 bpluciferase reporter recombinants, we determined that the 1 bp to 600 bp fragment upstream of ORF was the core regulatory sequence of LRP16, which might play a major role in expression regulation. Further cisacting element prediction indicated that multiple cisacting elements, including TAg, IL6, ZF5, Ets, estrogen receptor, retinoic acid receptor, and XPF1 cisacting elements, had more than 5 repeats in the 623 bp to 200 bp region.
1020 Thus, we speculated that LRP16 may be involved in many physiologic and pathologic processes such as the cell cycle, hematopoiesis regulation, cell differentiation, tumorigenesis, and stress reactions. At the same time, the LRP16 protein modification sites and structural predictions showed that LRP16 had multiple chemical modification sites involved in major biologic functions (eg, phosphorylation and glycosylation), as well as sequences homologous at the end of human histone H2A1C (an H2AX family member), such as hismacro, COG2110, and A1pp.
Since H2AX is related to DNA damage repair and chromosom e structural stability, mutation on this gene could lead to cancer. 21,22 Therefore, it is likely that the protein is related to cellcycle regulation, genetranscription activation and inhibition, DNA damage repair, and tumorigenesis. This is consistent with our analysis of the regulationrelated cisacting elements of the promoter region, which should direct further study of the LRP16 gene function.
Through establishing HL60 and K562 cell lines that overexpressed LRP16, our study found that LRP16overexpression could inhibit UVinduced DNA damage in HL60 cells and promote proliferation of K562 cells. The proliferation/promoting effect was achieved through promoting cells entering the S phase from the G 0 phase. This experimental result is consistent with the promoter regulatory analysis of LRP16 and the functional prediction of the encoded protein, which were also confirmed by experiments using the breast cancer cell line MCF7 as an experimental model.
3
In summary, this study explored bioinformatic prediction methods for gene function using a combination of genepromoter analysis and protein structure and function prediction, which provided important guidance for clarifying the function of a novel gene and demonstrated advantages that were economical, accurate, and fast. 
